Quality of life in inflammatoryboweldisease in Tunisian patients

##plugins.themes.academic_pro.article.sidebar##

Published May 14, 2018
Download
pdf
Vol. 95 No. 12 (2017): Issue Dec 2017

##plugins.themes.academic_pro.article.main##

Soumaya Mrabet
Mehdi Ksiaa
Nour Elleuch
Hanène Jaziri
Imed Ben Mansour
Ahlam Braham
Salem Ajmi
Aida Ben Slama
Ali Jmaa

Abstract

Background : The management of the health-related quality of life (HRQL) is increasingly considered as an important treatment goal in chronic diseases including inflammatory bowel diseases (IBD).
Aim :The aim of our study was to determine the impact of IBD on HRQLand identify the factors involved in the deterioration of HRQL in these patients.
Methods: We conducted a case-control study including 108 patients; 66 had Crohn's disease (CD) and 42 had ulcerative colitis (UC). In the measurement of HRQL, we used a general questionnaire "Short Form 36: SF36" and a specific questionnaire "Tunisian Inflammatory Bowel Disease Questionnaire: T-IBDQ".
Results: HRQL of patients was worse than controls with a statistically significant difference for six of the eight dimensions of the SF 36 "Physical Functionning PF", "Role Physical RP", "General health GH","SocialFunctionning SF "," Mental Health MH "and" Role Emotional RE "as well as the Mental summary score (MCS) and the Physical summary score (PCS ) (p <0.05). The factors involved in the alteration of HRQL were: age <30 years, poor socioeconomic conditions, disease activity, use of corticosteroids, a number of surgeries ≥2 and anterior hospitalization history.
Conclusion: In this study, IBD cause impaired HRQL affecting almost all areas of the SF 36 questionnaire. Incriminated factors may be related to the patient, disease and even treatment.

Keywords:

Inflammatory bowel diseases, Health related quality of life, SF 36 questionnaire, Specific Inflammatory bowel disease questionnaire.

##plugins.themes.academic_pro.article.details##

References

  1. Word Health Organization Quality Of Life Group. Study protocol for the World Health Organisation project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res 1993;2:153-9.
  2. Testa MA, Simonson DC et al. Assessment of quality of life outcomes. New Engl J Med 1996;334:835-40.
  3. Guermazi M, Allouch C, Yahia M et al. Translation in Arabic, adaptation and validation of the SF-36 Health Survey for use in Tunisia. Annals of Physical and Rehabilitation Medicine 2012; 55: 388-403.
  4. Mnif L, Medhioub M, Boudabbous M et al. Validation de la version tunisienne du questionnaire de la qualité de vie dans les maladies inflammatoires chroniques de l'intestin. LA TUNISIE MEDICALE 2013 ; 91 (12) : 685-692.
  5. Wade JE, Sherbourne CD et al. The MOS 36-item short-form health survey (SF-36). Medical Care 1992;30:473-83.
  6. Cheung WY, Garratt AM, Russell IT, Williams JG. The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. development and validation. J Clin Epidemiol. 2000;53(3):297-306.
  7. Guyatt G, Mitchell A, Irvine EJ et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804 -10.
  8. Pallis A.G, Mouzas I.A, Vlachonikolis IG. The inflammatory bowel disease questionnaire : a review of its national validation studies . InflammBowel Dis 2004 ; 10 (3):261-69.
  9. Bernklev T, Jahnsen J, Lygren I. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and comparison with general population norms. InflammBowel Dis 2005;11:909-18.
  10. Bastida G, Nos P, Aguas M. The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients. Gastroenterology 2010;10:26.
  11. Gert Huppertz-HaussMD, Langholz E, Selwyn O et al. Health-related Quality of Life in Inflammatory Bowel Disease in a European-wide Population-based Cohort 10 Years After Diagnosis. InflammBowel Dis 2015;21:337-344.
  12. Andersson P, Olaison G, Bendtsen P. Health related quality of life in Crohn's proctocolitis does not differ from a general population when in remission. Colorectal Dis 2003;5:56-62.
  13. Ren WH, Lai M, Chen Y. Validation of the mainland chinese version of the inflammatory bowel disease questionnaire (IBDQ) for ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2007;13:903-10.
  14. Pallis AG, Vlachonikollis IG, Mouzas IA. Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the inflammatory bowel disease questionnaire. Digestion 2001; 63: 240-6.
  15. Rubin GP, Hungin APS, Chinn DJ. Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Aliment PharmacolTher 2004;19:529-35.
  16. Saibeni S, Cortinovis I, Beretta L. Gender and disease activity influence health-related quality of life in inflammatory bowel diseases. Hepatogastroenterology 2005;52:509-15.
  17. J. Burisch, P.Weimersa, N. Pedersen et al.Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease.Journal of Crohn's and Colitis 2014; 8:1030-1042
  18. Iglesias M, Vázquez I, Barreiro de Acosta M. Health related quality of life in patients with Cohn´s disease in remission. Rev Esp EnfermDig 2010;102:624-30.
  19. LÓpez Blanco B, Moreno-Jiménez B, DevesaMúgica JM. Relationship between socio-demographic and clinical variables, and health-related quality of life in patients with inflammatory bowel disease. Rev Esp EnfermDig 2005;97:887-98.
  20. J. Magalhaes, FD. Castro, P. Carvalho, S. Leite, MJ. Moreira, J Cotter. Quality of life in patients with inflammatory bowel disease: importance of clinical, demographic and psychosocial factors. ArqGastroenterol 2014;51:192-7.
  21. Mnif L, Mzid A, Amouri A, Chtourou L, Tahri N. Health - related quality of life in patients with inflammatory bowel disease: a Tunisian study. TunisMed- 2010 ;88: 933-6.
  22. Van der Have M, van der Aalst KS, Kaptein AA, et al. Determinants of health-related quality of life in Crohn's disease: A systematic review and meta-analysis. J CrohnsColitis 2014;8:93-106.
  23. Kuriyama M, Kato J, Kuwaki K. Clinical factors that impair health-related quality of life in ulcerative colitis patients vary with the disease duration. Eur J GastroenterolHepatol 2008;20:634-41.
  24. Feagan BG, Yan S, Bala M, et al. The effects of infliximab maintenance therapy on health-related quality of life. Am J Gastroenterol 2003;98:2232-2238
  25. Loftus EV, Feagan BG, Colombel JF, et al. Effects of adalimumab maintenance therapy on health related quality of life of patients with Crohn's disease: patientreported outcomes of the CHARM trial. Am J Gastroenterol 2008;103:3132-3141.
  26. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006;55 :36-58.
  27. Agostini A, Moretti M, Calabrese C et al.Attachment and quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis 2014;29:1291-1296.
  28. Wright EK,Kamm M, CruzP. Effect of Intestinal Resection on Quality of Life in Crohn's Disease. Journal of Crohn's and Colitis 2015, 452-462.